Skip to main content

Robert E. Claypoole

Equibles does not estimate personal net worth.

Get an email with a short summary when Bioventus Inc. publishes a filing, an earnings call transcript or a press release.

Get BVS alerts

About Robert E. Claypoole

Robert E. Claypoole is recorded as Board Member at Bioventus Inc. (BVS) since January 1, 2024 and CEO at Bioventus Inc. (BVS). The newest filing on record that lists Robert E. Claypoole as CEO and Board Member at Bioventus Inc. (BVS) is dated April 22, 2026. Bioventus Inc. reported in an 8-K filed January 12, 2024 that Robert E. Claypoole was appointed President and Chief Executive Officer, effective January 10, 2024. Bioventus Inc. reported in an 8-K filed December 21, 2023 that Robert E. Claypoole was appointed Class III director, effective January 10, 2024. Bioventus Inc. reported in an 8-K filed December 21, 2023 that Robert E. Claypoole was appointed President and Chief Executive Officer, effective January 10, 2024. The proxy statement of Bioventus Inc. reports total compensation of $4,299,108 for Robert E. Claypoole in fiscal 2025, including a base salary of $824,110. Disclosed compensation is on record for 2 fiscal years. Bioventus Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Bioventus Inc. includes Anthony Bihl (CEO), Anthony P. Bihl III (CEO and Board Member), Robert Claypoole (CEO and Board Member) and 7 others.

“Robert E. Claypoole succeeded Mr. Bihl as President and Chief Executive Officer of the Company on January 10, 2024.”
Bioventus Inc. Form 8-K, filed January 12, 2024 · Read the filing
“On December 19, 2023, Bioventus Inc. (the "Company") announced that Robert E. Claypoole has been appointed as the Company's President and Chief Executive Officer, and as a Class III director of the Company, effective January 10, 2024 ("Start Date")”
Bioventus Inc. Form 8-K, filed December 21, 2023 · Read the filing

Affiliation history

Company network

Current role

Medical Devices · Healthcare

CEO, Board Member

2024-01-01–present

Leadership on record at Bioventus Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Bioventus Inc. (BVS) $824,110 $4,299,108
2024 Bioventus Inc. (BVS) $780,328 $6,379,010

Recent activity